株式会社アイジーン
Matsuyama, JP · 1 known investors
iGene develops plasma-based molecular introduction technology for cellular engineering, enabling safe and efficient delivery of DNA and proteins into cells. The company targets applications in gene therapy, regenerative medicine, agriculture, and health/beauty sectors.